The molecular landscape of prostate cancer is characterized by recurrent genomic alterations, including the fusion of ETS family genes such as ERG, ETV1, ETV4, or FLI1, and genetic mutations involving SPOP, FOXA1, or IDH1 [4]. Here, FOXA1 is linked to Familial prostate cancer.